News from Quartz

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Investors Crypto Assets Shares Cryptocurrency Stock Stock Market Ethereum Price Markets Xrp Investment Blockchain Etf Stablecoin Sec Eth Bse Trade Ipo Index Solana Earnings Revenue China Coinbase Inflation Token Wall Street Nasdaq Interest Rates Sensex Gold Usd Trade War Nse Traders Economy Treasury Tesla Profit Federal Reserve Bse Sensex Digital Assets Sp 500 Issuer Silk Road Ibit Etf Us Tech Stocks Trump Tower Investment Consortium Plume Network Eu Negotiations Interest Expenses Pune

Filter by:

Eli Lilly × Past year × Quartz ×

Quartz • May 30, 2025

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Despite its initial leadership in the growing weight loss medication sector, Novo Nordisk has recently experienced a decline in market share compared to Eli Lilly, affecting its fi...

Read Full Article →

Quartz • May 12, 2025

Eli Lilly stock sinks as pharma misses out on the market rally

Eli Lilly experienced a notable decline in share value as broader pharmaceutical stocks failed to benefit from the market’s upward movement, influenced by new government policies o...

Read Full Article →

Quartz • May 12, 2025

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

The superior results of Eli Lilly’s medication compared to Novo Nordisk’s in the recent trial may influence market dynamics and investor confidence within the competitive obesity t...

Read Full Article →